Safety of the primary percutaneous coronary intervention strategy combining pre-hospital prasugrel, enoxaparin and in-hospital bivalirudin in acute ST-segment elevation myocardial infarction

BACKROUND: The optimal antithrombotic treatment during a primary percutaneous coronary intervention (pPCI) is not known. This single center registry study aims to assess the safety of a novel antithrombotic regimen combining enoxaparine and prasugrel at presentation, followed by bivalirudin at the c...

Descripción completa

Detalles Bibliográficos
Autores principales: Viikilä, Juho, Nieminen, Tuomo, Tierala, Ilkka, Laine, Mika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967509/
https://www.ncbi.nlm.nih.gov/pubmed/27475059
http://dx.doi.org/10.1186/s12872-016-0333-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967509/
https://www.ncbi.nlm.nih.gov/pubmed/27475059
http://dx.doi.org/10.1186/s12872-016-0333-0

Ejemplares similares